SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Inflazyme Pharmaceuticals (T.IZP)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Chuca Marsh who wrote (888)4/13/1998 11:43:00 PM
From: Sean Janzen  Read Replies (1) of 1501
 
Chucka,

How does your response address Bob's question or IZP's technology?

Researchers find protein that protects cancer

WASHINGTON (AP) - Researchers have found a protein that gives cancer cells a resistance against radiation and chemotherapy by blocking a natural process that usually causes cells to die.

In studies to be published today in the journal Science, three teams of researchers report that laboratory tests show that cancer cells have a protective protein, called nuclear factor kappa B, or NF-KB, that blocks a natural cell-killing action.

The research was conducted at Massachusetts Institute of Technology in Cambridge, Mass., the Salk Institute in La Jolla, Calif., and the University of North Carolina in Chapel Hill, N.C.

Earlier research had found that when cancer is treated with chemotherapy or radiation, the cells are forced to go through a process called apoptosis, a type of cell suicide.Apoptosishrnm-

The studies showed that NF-KB prevented the cancer cells from going through apoptosis, thus giving cancer a resistance to radiation and chemotherapy.

In the MIT laboratories, researchers blocked the action of NF-KB in both tumor and non-tumor cells. The cells were then treated with tumor necrosis factor, or TNF. Cells of both types were killed.

TNF is a natural cancer cell killer. Earlier studies had shown that cells with active NF-KB could not be killed by TNF.

At Salk, researchers also inhibited NF-KB and found that cancer cells could be more easily killed. The researchers said the work suggests that drugs that block the action of NF-KB could be used to treat both cancer and some bacterial and viral infections.

Researchers at the University of North Carolina blocked the action of NF-KB in cultured tumor cells and found that the cells could be more easily killed by both chemotherapy agents and by radiation.ÿ
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext